1. Cryoprotectant Use

Polyvinyl pyrrolidone (PVP), with the general formula (C₆H₉NO)_n, is a widely used cryoprotective agent (CPA) due to its ability to stabilize cells and tissues during freezing and thawing. It functions primarily as a non-penetrating cryoprotectant, meaning it predominantly remains in the extracellular space. This characteristic differentiates it from penetrating cryoprotectants like dimethyl sulfoxide (DMSO) or glycerol, which permeate cell membranes.

2. Applications

PVP finds applications in various cryopreservation protocols, including:

1. Plant cell and tissue culture: Preservation of protoplasts, calli, and meristems.
2. Embryo cryopreservation: Utilized in the vitrification of oocytes and embryos.
3. Red blood cell cryopreservation: Offers an alternative to glycerol in specific cases.
4. Organ and tissue preservation: Research is ongoing for its potential in preserving larger biological structures.
5. Pharmaceutical formulations: Used as a stabilizer for freeze-dried pharmaceuticals and vaccines.

For example, in plant cryopreservation, PVP is often used in combination with other CPAs like sucrose and glycerol to provide comprehensive protection against freeze-induced damage.

3. Mechanism of Action

PVP primarily acts by modifying the physicochemical properties of the extracellular solution during freezing. It increases solution viscosity, reducing ice crystal growth and minimizing mechanical damage to cells. It also contributes to osmotic buffering, mitigating the potentially harmful effects of osmotic stress during the freezing and thawing processes. While generally non-penetrating, some low molecular weight PVP species might enter cells, offering intracellular protection to a lesser extent than dedicated penetrating CPAs.

4. Concentration and Protocol

The optimal PVP concentration depends on the specific application and cell type. Commonly used concentrations range from 5% to 40% (w/v). A typical protocol might involve a stepwise addition of PVP to the cell suspension, allowing for equilibration at each step. For example, a protocol for plant protoplast cryopreservation could include pre-culture in a solution containing 0.5 M sucrose and 5% PVP, followed by increasing the PVP concentration to 10% before freezing.

Practical Guideline: Always perform preliminary experiments to determine the optimal concentration and protocol for your specific system.

5. Safety and Handling

PVP is generally considered safe to handle. However, it is advisable to wear standard laboratory attire, including gloves and eye protection. Inhaling PVP powder should be avoided. If skin contact occurs, rinse with water. Refer to the specific material safety data sheet (MSDS) provided by the manufacturer for detailed safety information.

6. Advantages

Compared to other cryoprotectants like DMSO, PVP exhibits lower toxicity to certain cell types. It also possesses excellent water solubility, simplifying preparation and handling. Its non-penetrating nature can be advantageous in certain applications where intracellular perturbation is undesirable. For instance, in embryo cryopreservation, PVP can reduce the risk of DMSO-induced developmental abnormalities.

7. Disadvantages

PVP can be relatively expensive compared to simpler cryoprotectants. Its high viscosity can sometimes hinder effective mixing and cell manipulation. Also, its efficacy can vary significantly between cell types and requires careful optimization.

8. Compatibility

PVP has demonstrated compatibility with various cell types and tissues, including plant cells, embryos, red blood cells, and certain types of stem cells. It has been successfully used for cryopreservation of plant protoplasts, mammalian embryos, and even some insect cells. However, its effectiveness can vary depending on the specific cells and requires preliminary testing.

9. Toxicity Profile

PVP is generally considered to have low toxicity. However, some studies have reported potential cytotoxic effects at high concentrations or prolonged exposures. It's crucial to optimize the concentration and exposure time for each application.

10. Solubility

PVP is readily soluble in water and other polar solvents like glycerol and ethylene glycol. This excellent solubility makes it easy to prepare stock solutions and incorporate it into cryopreservation media.

11. Storage Conditions

PVP powder should be stored in a cool, dry place away from direct sunlight. PVP solutions can be stored at 4°C for short periods or at -20°C for longer-term storage. Avoid repeated freeze-thaw cycles.

12. Interaction with Other CPAs

PVP can be used in combination with other cryoprotectants, such as DMSO, glycerol, ethylene glycol, and sugars like sucrose or trehalose. These combinations often provide synergistic protection during cryopreservation. For example, PVP is frequently used with DMSO in vitrification protocols for oocytes and embryos.

13. Regulatory Status

PVP is generally recognized as safe (GRAS) by the US Food and Drug Administration (FDA) for specific applications, including use in food and pharmaceuticals. However, its use in cryopreservation may be subject to specific regulatory requirements depending on the intended application and jurisdiction.

14. Environmental Impact

PVP is considered biodegradable, albeit slowly. Its environmental impact is generally low compared to some other cryoprotectants, but proper disposal according to local regulations is still essential.

15. Historical Context

PVP was first synthesized in the 1930s. Its use as a plasma expander during World War II led to its exploration as a cryoprotective agent in subsequent decades. Since then, it has become a valuable tool in various cryopreservation applications.

16. Alternative Cryoprotectants

Alternatives to PVP include:

1. DMSO: Highly effective but can be toxic at high concentrations.
2. Glycerol: Less toxic than DMSO but can cause osmotic stress.
3. Ethylene glycol: Another penetrating CPA with potential toxicity concerns.
4. Trehalose: A non-reducing disaccharide that acts as a non-penetrating cryoprotectant.
5. Hydroxyethyl starch (HES): A non-penetrating colloid similar to PVP.

The choice of cryoprotectant depends on the specific application and the balance between efficacy and toxicity.

17. Physical Properties

PVP is a hygroscopic, amorphous powder. It is available in various molecular weights, which affect its viscosity and potential cell penetration. Higher molecular weights result in greater viscosity and reduced cell permeability.

18. Cost-Effectiveness

PVP can be more expensive than simpler cryoprotectants like glycerol or DMSO. However, its effectiveness and lower toxicity in certain applications can justify the higher cost.

19. Known Issues

Potential issues associated with PVP use include variability in quality between different sources and batches, potential for aggregation at high concentrations, and the need for careful optimization of concentration and protocol for specific applications.

20. Handling Instructions

To prepare a PVP solution, accurately weigh the desired amount of PVP powder and slowly add it to the solvent (usually water or a buffer solution) while stirring continuously. Avoid vigorous shaking, which can cause foaming. Sterilize the solution by filtration if necessary. Always refer to the specific instructions provided by the manufacturer.

21. Conclusion

PVP is a versatile cryoprotectant with valuable applications in various fields, from plant cryopreservation to embryo vitrification. Its unique properties, including its non-penetrating nature and low toxicity for some cell types, make it a valuable alternative to traditional cryoprotectants. However, careful optimization of its use is essential to maximize its effectiveness and minimize potential drawbacks. Ongoing research continues to explore its potential in new cryopreservation applications.

References

1. Fahy, G. M. (1986). The relevance of cryoprotectant “toxicity” to cryobiology. Cryobiology, 23(1), 1-13.

2. Kuleshova, L. L., Shaw, J. M., & MacFarlane, D. R. (2004). Vitrification in plants: a new approach to organ cryopreservation. Cryo Letters, 25(3), 171-186.

3. Engelmann, F. (2011). Use of osmolytes in plant cryopreservation: a review. Plant Cell, Tissue and Organ Culture (PCTOC), 104, 133-142.

4. Sakai, A., & Engelmann, F. (2007). Vitrification, encapsulation-vitrification and droplet-vitrification: a review. Cryo Letters, 28(3), 151-172.

5. Rall, W. F., & Fahy, G. M. (1985). Ice-free cryopreservation of mouse embryos at −196 degrees C by vitrification. Nature, 313(6003), 573-575.

6. Kasai, M. (2014). Cryopreservation of mammalian embryos and oocytes. Current Opinion in Obstetrics and Gynecology, 26(3), 200-206.

7. Oldenhof, H., Wolkers, W. F., Schoonen, W. G. E. J., & Hoekstra, F. A. (2005). Crosslinking of the cytoplasmic matrix as an important factor in plant vitrification. Plant Physiology, 139(4), 1568-1579.

8. Bianchi, F., Li, Y., Paoli, D., & Barba, M. (2012). Pre-treatments for high-quality RNA extraction from grapevine berry skins. BMC Research Notes, 5, 153.

9. Crowe, J. H., Crowe, L. M., & Chapman, D. (1984). Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science, 223(4637), 701-703.

10. Meryman, H. T. (2007). Cryopreservation of living cells: principles and practice. Transfusion, 47(s1), 9S-16S.

11. Fuller, B. J., Lane, N., & Benson, E. E. (Eds.). (2004). Life in the frozen state. CRC Press.

12. Taylor, M. J., Song, Y. C., & Brockbank, K. G. M. (2004). Vitrification in tissue preservation: new developments. In B. J. Fuller, N. Lane, & E. E. Benson (Eds.), Life in the Frozen State (pp. 603-642). CRC Press.

13. Pegg, D. E. (2007). Principles of cryopreservation. Methods in Molecular Biology, 368, 39-57.

14. Baudot, A., & Odagescu, V. (2015). Cryopreservation of complex systems. Springer.